PFE - COVID-19: Distinguishing The Facts From The Hysteria
- Vaccine programs are progressing but it's still too early to know if they will be successful.
- Leading candidate vaccines from Pfizer/BioNTech, Moderna, Astra Zeneca/Oxford University and Inovio will not be ready for evaluation before the US election.
- Meantime with northern hemisphere winter approaching, COVID-19 cases are resurging in both Europe and the US.
- Lack of certainty about development of a successful vaccine means social distancing, masks, testing and isolation are going to be crucial.
- This is a time of great uncertainty that must eventually impact the market.
For further details see:
COVID-19: Distinguishing The Facts From The Hysteria